AltPep, UW spinout led by Valerie Daggett, raises $23.1M Series A to develop early-detection and therapeutics for Alzheimer’s

Seattle biotech AltPep, spun out of the University of Washington in 2019 and led by founder/CEO Valerie Daggett, raised $23.1 million in a Series A to develop detection tools and preclinical therapies for Alzheimer’s and other amyloid protein diseases. The company’s technology, based on UW-licensed research into alpha-sheet protein structures, will support early detection efforts and expansion into a new 7,500 sq ft Seattle lab.

VValerie Daggett AAltPep UUniversity of Washington